Golub, Jonathan E <br/><br/>
Isoniazid preventive therapy, HAART and   tuberculosis risk in HIV-infected adults in South   Africa: a prospective cohort.  [electronic resource] 

 -  AIDS (London, England)  Mar 2009 
 - 631-6 p.  digital 
<br/><br/> Publication Type: Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1473-5571 
<br/><br/><label>Standard No.: </label>10.1097/QAD.0b013e328327964f  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AIDS-Related Opportunistic Infections--epidemiology<br/>Adult<br/>Anti-HIV Agents--therapeutic use<br/>Antiretroviral Therapy, Highly Active<br/>Antitubercular Agents--therapeutic use<br/>CD4 Lymphocyte Count<br/>Epidemiologic Methods<br/>Female<br/>HIV Infections--drug therapy<br/>Humans<br/>Isoniazid--therapeutic use<br/>Male<br/>Middle Aged<br/>Sex Factors<br/>South Africa--epidemiology<br/>Treatment Outcome<br/>Tuberculosis--epidemiology